Ghrelin is an orexigenic and metabolic signaling peptide in the arcuate and paraventricular nuclei.
Ghrelin is the endogenous ligand for an orphan G-protein-coupled receptor, growth hormone secretagogue receptor (GHS-R) (34, 58) . Both rat and human ghrelin peptides consist of 28 amino acids differing only in two residues and both are modified at Serine 3 by n-octanoic acid. (34, 58) . The fatty acid (n-octanolyl) side chain at Serine 3 is a unique biochemical characteristic associated with its bioactivity and identifies the peptide hormone as an endogenous factor unique in mammalian biology (29) . In situ hybridization and immunohistochemical analyses indicate that ghrelin-containing cells are a distinct endocrine cell type localized in the mucosal epithelium of the stomach (18, 21, 48) .
Recent evidence suggests that the gastric peptide plays a particularly important role in the regulation of energy homeostasis and that this role is exerted at the level of the central nervous system (CNS). Central injections of ghrelin elicit food intake (4, 8, 24, 68) and chronic ventricular administration to rodents induces body weight gain and enhanced body fat mass deposition (28, 64) . Indeed ghrelin appears to interact with other peptidergic systems within the hypothalamus, including neuropeptide Y/agoutirelated peptide (NPY/AGRP) neurons of the arcuate nucleus (Arc) (25, 61, 67) . This latter finding suggests that hypothalamic nuclei may be key sites of action for the peptide. In support of this hypothesis, a limited number of microinjections studies, including our own data, indicate that ghrelin administration into discrete hypothalamic nuclei stimulates appetite and/or energy metabolism (16, 37, 66, 68 ). Ghrelin's orexigenic action is comparable to that of NPY in magnitude (62, 68) and similar changes in nutrient partitioning have been reported with neuropeptide Y (NPY) (11) (12) (13) (14) (15) (16) (17) . Paraventricular nucleus (PVN) injections of NPY evoke a marked increase in respiratory quotient (RQ), independent of its feeding stimulant effects (10) (11) (12) (13) (14) (15) (16) (17) 38) . Interestingly, in comparison with peripheral treatment, ghrelin alters food intake and body weight greater than 1000-fold more potently after central administration (28) , consistent with the hypothesis that the 4 peptide influences energy homeostasis predominantly through the stimulation of central mechanisms. Moreover, these effects are observed using physiologically relevant doses (64) .
Based on such findings we propose that ghrelin alters appetite and energy metabolism, including the promotion of carbohydrate oxidation and the conservation of fat stores, by an action on hypothalamic circuits mediating positive energy balance. In the present study we examined the effects of ghrelin administration in two key regions of the hypothalamus, the Arc and PVN, in order to examine the peptide's effects on food intake and energy substrate utilization as measured by indirect calorimetry. We also examined a possible interactive role for ghrelin and NPY on these measures. Cannulae were implanted 4 mm dorsal to target as described previously (14, 15) according to the following coordinates (43) testing. In feeding studies (n=8/group), rats were tested in their home cages and food intake, corrected for spillage, was measured 2 and 4 h postinjection. In metabolic testing (n=9), identical injection procedures were followed. Immediately after treatment, rats were placed in individual chambers of the metabolic apparatus where O 2 consumption and CO 2 production were measured over 4 h. Food and water were not available during this time.
MATERIALS AND METHODS

Subjects
In separate groups of male and female rats with cannulae aimed at the PVN, ghrelin (2.5, 5 or 10 pmol) or vehicle was administered 5 min before injection of NPY (50 pmol) or vehicle. NPY administration coincided with the start of the dark cycle. Feeding (n=9) and metabolic (n=8) protocols were identical to the above paradigms except that food 6 intake and RQ were measured over 2 h postinjection. Again, injections were separated by 4 days with treatments conducted in randomized order. In the control condition, rats received two injections of sterile saline. Ghrelin and NPY coinjections were examined in the PVN alone since only PVN injections of NPY are reported to alter RQ (10) (11) (12) (13) (14) (15) (16) (17) 38) .
Statistical and histological analyses. Data were analyzed using two and three-way repeated measures analyses of variance (ANOVA) followed by post hoc analysis of individual mean comparisons were appropriate. The criterion for statistical significance was p<0.05. The accuracy of all cannula placements was confirmed via histological assessment as described previously (11, 15) . Sections were examined by light microscopy and viewed relative to the stereotaxic atlas of Paxinos and Watson (43) . All animals reported here were found to have injector tracts extending into the appropriate target nucleus.
RESULTS
Figures 1 and 2 depict the dose-response effects of ghrelin in male and female rats after injection into either the Arc or PVN of the hypothalamus. Ghrelin increased food intake when administered into the Arc of male and female rodents (F(1,14) =56.6, p<0.0001). A similar effect on food intake was observed upon injection into the PVN (F(1,14) =146.1, p<0.0001). Intake was significantly increased at both 2 and 4 h into the dark period. The effect of ghrelin on energy substrate utilization is illustrated in figure 3 and 
DISCUSSION
In the present study, ghrelin stimulated eating when injected into the Arc and PVN.
This effect was observed in both male and female rats. Additionally, ghrelin injections into these same anatomical sites within the hypothalamus altered energy substrate utilization as reflected in an increase in RQ. The elevation in RQ elicited by Arc and PVN injections of ghrelin, to values near or exceeding 1.0, indicates that the peptide acts locally to promote carbohydrate oxidation and fat storage (7, 33) . The diversion of metabolism away from fat oxidation in favor of carbohydrate utilization and fat synthesis, and its orexigenic action, are in fact consistent with the effects of NPY administration into the PVN (10) (11) (12) 15) . Indeed our findings demonstrate that ghrelin enhances the feeding 8 stimulant action of NPY and potentiates NPY's effects on RQ and we did not observe any sex-related differences.
Ghrelin binds to a G-protein coupled receptor, the GHS-R, which has two subtypes, 1a and 1b and their sequences do not show significant homology with other known receptors (58) . The GHS-R 1a is believed to be highly conserved across species and the human 1a subtype shares 96% identity with the rat 1a receptor (58) . While ghrelin and synthetic GHS bind with high affinity to the GHS1a receptor, this is not the case with the GHS1b, and the functional role of the 1b receptor remains poorly defined (30, 41) .
Expression for the GHS1a receptor is reported in the hypothalamus and anterior pituitary (30, 56) . Recently, a transgenic rat model overexpressing antisense oligonucleotides against the GHS-R 1a was reported to exhibit decreased food intake and lower body fat Indeed our current understanding of the involvement of hypothalamic systems in metabolic regulation indicates that a complex network of neuropeptide and transmitter systems are involved (51, 53, 54, 60) . It is also clear that extrahypothalamic mechanisms participate in the process (53, 54) . Within the hypothalamus, distinct effects on food intake and energy metabolism have been reported in discrete regions or nuclei. In addition to the effects of NPY described above, some of the other appetite-stimulating neuropeptides include melanin concentrating hormone, hypocretins/orexins, AGRP, CRH and urocortin (6, 19, 44, 49) . AGRP is co-produced with NPY in the same Arc neurons (23, 36, 42) . Appetite suppressive neuropeptides include the POMC derivative, α-melanocyte-stimulating hormone (αMSH), and cocaine and amphetamine related transcript (CART), co-produced in a separate population of Arc neurons. (1, 26, 40, 59 ).
Leptin receptors have been localized to the hypothalamus, particularly the Arc nucleus, where they exert primary feedback signaling by influencing the production of appetite stimulating and inhibiting peptides (20, 22, 39, 69) . Interestingly, ghrelin also appears to act on these same leptin-responsive neurons in the rat Arc and it is now proposed that ghrelin-sensitive circuits are dynamically regulated by leptin (27) .
During food deprivation leptin levels rapidly decline (50) and the production of NPY and AGRP is enhanced, while POMC neuronal activity is suppressed (45) (46) (47) 50, 52) . At the same time, circulating ghrelin levels increase (2, 64, 65) , possibly augmenting the action of leptin by directly activating Arc NPY/AGRP neurons and inhibiting POMC neurons. Thus circulating ghrelin and leptin, although responding to food deprivation in an inverse manner, may regulate hypothalamic peptidergic systems, directed at preventing further energy deficit. Moreover, whereas plasma levels of ghrelin decrease in obesity, leptin levels increase (29, 31, 59, 64, 65) reflecting a physiological adaptation to a state of positive energy balance.
With respect to specific hypothalamic peptidergic circuits, as outlined above, recent attention has focused in large part on Arc neurons producing α-MSH, an anorectic peptide that enhances energy expenditure (42) and their interrelationship with Arc neurons producing both NPY and AGRP (36) . AGRP is an endogenous antagonist of α-MSH (36) . The interaction of these two distinct populations of neurons is considered significant in the regulation of energy homeostasis. It is proposed that these two major hypothalamic pathways mediate the action of ghrelin on energy balance (41, 55, 63) .
Ghrelin itself increases AGRP and NPY mRNA levels in the hypothalamus (32) .
Conversely, the orexigenic action of ghrelin is abolished or reduced by NPY Y1 receptor antagonism, melanocortin agonists, and antisera to both NPY and AGRP (3, 55, 63) .
Consistent with a direct action on hypothalamic structures, ICV ghrelin administration activates c-Fos expression in multiple hypothalamic areas including the Arc, PVN, dorsomedial nucleus and lateral hypothalamus (35) .
While relatively few studies have examined the effects of ghrelin on appetite after direct microinjection into CNS tissue (16, 24, 37, 66, 68) , our findings extend current knowledge of the anatomical sites of action within the hypothalamus wherein ghrelin acts to alter feeding and energy metabolism, and where the peptide interacts with NPY mechanisms. Overall, our data are consistent with the hypothesis that ghrelin alters appetite and energy metabolism, including the promotion of carbohydrate oxidation and 11 the conservation of fat stores, by an action on hypothalamic circuits mediating positive energy balance. Fig. 1 . Food intake in male and female rats after ghrelin injection into the Arc. Data represent mean intakes (± SEM) measured at 2 h and 4 h. *P<0.05 compared to vehicle. 
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